These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
554 related articles for article (PubMed ID: 19646764)
1. Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function. Kaneda Y; Jayathilak K; Meltzer HY Psychiatry Res; 2009 Sep; 169(2):178-9. PubMed ID: 19646764 [TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
3. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment. Kaneda Y; Jayathilak K; Meltzer H Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677 [TBL] [Abstract][Full Text] [Related]
4. Cognitive function in schizoaffective disorder and clinical subtypes of schizophrenia. Goldstein G; Shemansky WJ; Allen DN Arch Clin Neuropsychol; 2005 Mar; 20(2):153-9. PubMed ID: 15708725 [TBL] [Abstract][Full Text] [Related]
5. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia. Jabben N; Arts B; Krabbendam L; van Os J Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699 [TBL] [Abstract][Full Text] [Related]
6. Initial and final work performance in schizophrenia: cognitive and symptom predictors. Bryson G; Bell MD J Nerv Ment Dis; 2003 Feb; 191(2):87-92. PubMed ID: 12586961 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients. Sánchez-Morla EM; Barabash A; Martínez-Vizcaíno V; Tabarés-Seisdedos R; Balanzá-Martínez V; Cabranes-Díaz JA; Baca-Baldomero E; Gómez JL Psychiatry Res; 2009 Oct; 169(3):220-8. PubMed ID: 19758705 [TBL] [Abstract][Full Text] [Related]
8. Asocial beliefs as predictors of asocial behavior in schizophrenia. Grant PM; Beck AT Psychiatry Res; 2010 May; 177(1-2):65-70. PubMed ID: 20163875 [TBL] [Abstract][Full Text] [Related]
9. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia. Fan X; Henderson DC; Nguyen DD; Cather C; Freudenreich O; Evins AE; Borba CP; Goff DC Psychiatry Res; 2008 May; 159(1-2):140-6. PubMed ID: 18423611 [TBL] [Abstract][Full Text] [Related]
10. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia. Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174 [TBL] [Abstract][Full Text] [Related]
11. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia. Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774 [TBL] [Abstract][Full Text] [Related]
12. Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia. Mohamed S; Bondi MW; Kasckow JW; Golshan S; Jeste DV Int J Geriatr Psychiatry; 2006 Aug; 21(8):711-8. PubMed ID: 16862606 [TBL] [Abstract][Full Text] [Related]
13. Neurocognitive correlates of response to treatment in formal thought disorder in patients with first-episode schizophrenia. Goldstein RZ; Giovannetti T; Schullery M; Zuffante PA; Lieberman JA; Robinson DG; Barr WB; Bilder RM Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):88-98. PubMed ID: 12050471 [TBL] [Abstract][Full Text] [Related]
14. Neurocognitive functioning in drug-naive patients with first episode of psychosis before and after treatment. Zaytseva Y; Gurovich I; Sarkisyan G; Sarkisyan V Psychiatr Danub; 2011 Sep; 23 Suppl 1():S155-7. PubMed ID: 21894125 [TBL] [Abstract][Full Text] [Related]
15. Evaluation sensitivity as a moderator of communication disorder in schizophrenia. Grant PM; Beck AT Psychol Med; 2009 Jul; 39(7):1211-9. PubMed ID: 19379529 [TBL] [Abstract][Full Text] [Related]
16. Cognitive functioning related to quality of life in schizophrenia. Matsui M; Sumiyoshi T; Arai H; Higuchi Y; Kurachi M Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):280-7. PubMed ID: 17884266 [TBL] [Abstract][Full Text] [Related]
17. Is quality of life associated with cognitive impairment in schizophrenia? Alptekin K; Akvardar Y; Kivircik Akdede BB; Dumlu K; Işik D; Pirinçci F; Yahssin S; Kitiş A Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):239-44. PubMed ID: 15694230 [TBL] [Abstract][Full Text] [Related]